FDA applicant
Bard Access Systems, Inc (Bas)[Wholly-Owned Subsidiary of Bd]
FDA records 1 decision for Bard Access Systems, Inc (Bas)[Wholly-Owned Subsidiary of Bd] (Salt Lake Ciy,, UT) in 2021: 1 510(k) clearance. All are in product code MHC (Needle, Interosseous). Its devices cite 1 predicate, 0 of them its own earlier devices. 2 recalls are linked to its devices, 2 Class I.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Bard Access Systems, Inc (Bas)[Wholly-Owned Subsidiary of Bd]’s devices, and how often a recall has named them.
FDA decisions per year
1in 2021
2026 so far, outlined.
Recalls per year
1in 2026
Class I Class II/III not classified
Planning a device like Bard Access Systems, Inc…’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) ReportOther applicant names beginning “Bard”
FDA records each applicant name separately; these may or may not be the same firm.